Multiple Sclerosis Drug Novartis Gains FDA Approval | ThirdAge
Links shared publicly online about this topic.
- 854total visits
Multiple Sclerosis Drug Novartis Gains FDA Approval | ThirdAge
View full resource at thirdage.com
Tags: Nervous System, Multiple Sclerosis, Multiple Sclerosis Medication, Drug, FDA, Novartis
Most Recently Shared on September 22, 2010 at 9:32 pm By:
Multiple sclerosis drug Novartis gains FDA approval! http://dld.bz/wDdx
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significantly Reduce Relapses And Delay Disability Progression
drugs.com — “Gilenya (fingolimod) is used to treat relapsing forms of multiple sclerosis. Includes Gilenya side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 22, 2010 at 11:17 pm By:
Drugs and Devices OW OW Health
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significant... http://bit.ly/dp1Zza #drug
Multiple Sclerosis Drug Novartis Gains FDA Approval | ThirdAge
thirdage.com — “Multiple Sclerosis drug Novartis has been approved by The Food and Drug Administration. Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has” View full resource at thirdage.com
Most Recently Shared on September 22, 2010 at 8:07 pm By:
Multiple Sclerosis Drug Novartis Gains FDA Approval: Multiple Sclerosis drug Novartis has been approved by The Foo... http://bit.ly/d2TMIA
Novartis gains FDA approval for new MS drug - Topix
topix.com — “Novartis gains FDA approval for new MS drug - Topix” View full resource at topix.com
Most Recently Shared on September 22, 2010 at 7:55 pm By:
Novartis gains FDA approval for new MS drug: Federal health regulators have approved the first pill to treat the u... http://bit.ly/cLsfR4
The Associated Press: Novartis gains FDA approval for new MS drug
google.com — “The Associated Press: Novartis gains FDA approval for new MS drug” View full resource at google.com
Most Recently Shared on September 22, 2010 at 3:27 pm By:
LHJ Health Editors Health Communicator
New drug, new hope? The FDA approved the first oral drug to treat multiple sclerosis today: http://bit.ly/bc6l4Y
Novartis gains FDA approval for new MS drug
physorg.com — “(AP) -- Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has traditionally been treated with injectable drugs.” View full resource at physorg.com
Most Recently Shared on September 22, 2010 at 2:34 pm By:
PhysOrg Health News Health News
Novartis gains FDA approval for new MS drug http://tw.physorg.com/204370436
Novartis gains FDA approval for new MS drug. http://dld.bz/wB4H
health.yahoo.net — “Novartis gains FDA approval for new MS drug. http://dld.bz/wB4H” View full resource at health.yahoo.net
Most Recently Shared on September 22, 2010 at 2:29 pm By:
LegalMedsDirect Health Business
Novartis gains FDA approval for new MS drug. http://dld.bz/wB4H
Novartis gains FDA approval for new MS drug: Federal health regulators have approved the first pill to treat the u... http://bit.ly/98XBse
health.yahoo.net — “Novartis gains FDA approval for new MS drug: Federal health regulators have approved the first pill to treat the u... http://bit.ly/98XBse” View full resource at health.yahoo.net
Most Recently Shared on September 22, 2010 at 1:58 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Novartis gains FDA approval for new MS drug: Federal health regulators have approved the first pill to treat the u... http://bit.ly/98XBse
Novartis gains FDA approval for Gilenya drug - MarketWatch
marketwatch.com — “FRANKFURT (MarketWatch) -- Swiss pharmaceutical giant Novartis AG said Wednesday that the Food and Drug Administration approved its multiple-sclerosis drug Gilenya, making it the first oral treatment indicated for relapsing forms of the disease available in the U.S. Gilenya reduces the frequency of MS relapses, or flare-ups, and helps slow the build-up of some of the physical problems caused by the disease, Novartis said. "A new treatment option that offers significant efficacy in the conve” View full resource at marketwatch.com
Most Recently Shared on September 22, 2010 at 8:06 am By:
Novartis gains FDA approval for Gilenya drug: FRANKFURT (MarketWatch) -- Swiss pharmaceutical giant Novartis AG sa... http://bit.ly/bbp0zZ
Advertisement
